NRP-1 Receptor Expression Mismatch in Skin of Subjects with Experimental and Diabetic Small Fiber Neuropathy

Abstract

The in vivo cutaneous nerve regeneration model using capsaicin is applied extensively to study the regenerative mechanisms and therapeutic efficacy of disease modifying molecules for small fiber neuropathy (SFN). Since mismatches between functional and morphological nerve fiber recovery are described for this model, we aimed at determining the capability of the capsaicin model to truly mimic the morphological manifestations of SFN in diabetes. As nerve and blood vessel growth and regenerative capacities are defective in diabetes, we focused on studying the key regulator of these processes, the neuropilin-1 (NRP-1)/semaphorin pathway. This led us to the evaluation of NRP-1 receptor expression in epidermis and dermis of subjects presenting experimentally induced small fiber neuropathy, diabetic polyneuropathy and of diabetic subjects without clinical signs of small fiber neuropathy. The NRP-1 receptor was co-stained with CD31 vessel-marker using immunofluorescence and analyzed with Definiens® technology. This study indicates that capsaicin application results in significant loss of epidermal NRP-1 receptor expression, whereas diabetic subjects presenting small fiber neuropathy show full epidermal NRP-1 expression in contrast to the basal expression pattern seen in healthy controls. Capsaicin induced a decrease in dermal non-vascular NRP-1 receptor expression which did not appear in diabetic polyneuropathy. We can conclude that the capsaicin model does not mimic diabetic neuropathy related changes for cutaneous NRP-1 receptor expression. In addition, our data suggest that NRP-1 might play an important role in epidermal nerve fiber loss and/or defective regeneration and that NRP-1 receptor could change the epidermal environment to a nerve fiber repellant bed possibly through Sem3A in diabetes.

Compartmentalized Encapsulation of Two Antibiotics in Porous Nanoparticles: an Efficient Strategy to Treat Intracellular Infections

“…Of note, nanoMOFs had no direct effect on S. aureus (minimum inhibitory concentration (MIC) > 250 µg mL −1 , Figure 5e). Therefore, the effect of the MOFs could be due to their intracellular ROS production, [41,42] without toxic effects of the J774 macrophages, [43,44] phenomenon which could be explored in a therapeutic context. In further studies we foresee the use of drugs with higher efficacy on S. aureus than AMOX and CL.…”

Opposing Effects of Neuropilin-1 and -2 on Sensory Nerve Regeneration in Wounded Corneas: Role of Sema3C in Ameliorating Diabetic Neurotrophic Keratopathy

“…Of note, NRP1 was reported to be upregulated in patients with diabetes with proliferative retinopathy and to mediate SEMA3A-induced vascular permeability ( 44 ), whereas NRP1 was found to inhibit pathological angiogenesis in the presence of SEMA3C ( 46 ). In the skin, elevated NRP1 was linked to epidermal nerve fiber loss and/or defective regeneration ( 47 ). Consistent with the contradicting role of NRP1, the levels of NRP1 remained the same in healing corneas of NL and DM mice, which express different levels of SEMA3A and SEMA3C.…”

Bottlenecks in the development of topical analgesics: molecule, formulation, dose-finding, and phase III design

“…In diabetes patients, the epidermal neuropilin-1 receptor expression is high in the epidermal layer of diabetic subjects suffering from polyneuropathy, compared to controls. Neuropilin-1 receptor trafficking toward the membranes of all epidermal cells in diabetes might play an important role in the development of SFN 26. An understanding of the exact pathogenesis in the skin in a variety of neuropathic pain syndromes is still preliminary, but, clearly, it will differ considerably in various syndromes.…”